|
|
AT A GLANCEGlossary |
|
|
Introduction |
|
|
Welcome to the UCSF AGRC course in Geriatrics and Gerontology |
|
|
Course Topics |
|
|
Overall Course Goals |
|
|
Philosophy |
|
|
Faculty |
|
|
Why Take This Course? |
|
|
The Multifaceted Face of Aging: 3 Cases |
|
|
Discussion of the Three Preceding Cases |
|
|
How To Use This Course |
|
|
Where To Start? |
|
|
Then What? |
|
|
How to Start--Case 1 |
|
|
How to Start--Case 2 |
|
|
Reflection on Two Cases |
|
|
Post Test |
|
|
Demography And Epidemiology |
|
|
The Changing Face of Aging: Objectives |
|
|
Local and Regional Variations Among Older Adults in the United States |
|
|
Implications of an Aging Society for Health Care Needs and Resources |
|
|
Common Chronic Conditions Associated with Advanced Age |
|
|
Post Test |
|
|
Biology and Physiology of Aging |
|
|
Introduction and Background |
| 2.1.1 | Table of Contents |
| 2.1.2 | Module Learning Objectives |
| 2.1.3 | Personal Exercise |
| 2.1.4 | Case Background |
| 2.1.5 | Historical View of Aging |
| 2.1.6 | Successful Aging |
| 2.1.7 | What is the Truth about Aging? |
| 2.1.8 | When Pathologies are Attributed to Aging |
| 2.1.9 | Aging or Disease? |
| 2.1.10 | Understanding Age-Related Changes |
|
|
Theories of Aging |
|
|
Physiological Changes with Aging |
|
|
Pharmacologic Considerations |
|
|
Post Test |
|
|
Socio-cultural And Psychologicial… |
|
|
Module Objectives |
|
|
Social Theories of Aging |
| 3.2.1 | Modernization Theory |
| 3.2.2 | Modernization Theory (II) |
| 3.2.3 | Criticisms of Modernization Theory |
| 3.2.4 | Role Theory |
| 3.2.5 | Role Theory (II) |
| 3.2.6 | Criticisms of Role Theory |
| 3.2.7 | Disengagement Theory |
| 3.2.8 | Activity Theory |
| 3.2.9 | Reflections (III) |
|
|
Psychological Development In Late Life |
|
|
Ethno-Cultural Issues And Age-Stratified Societies |
|
|
Late-Life Transitions |
| 3.5.1 | Normative Transitions in Later Life |
| 3.5.2 | "Off Time" Transitions |
| 3.5.3 | Reflections (VII) |
|
|
Dependent Elders: Special Concerns |
| 3.6.1 | Adult Guardianship in Euro-American Societies |
| 3.6.2 | Elder Abuse |
| 3.6.3 | Caregiving: Informal |
| 3.6.4 | Caregiving: Formal |
| 3.6.5 | Residential Care |
| 3.6.6 | Ageism and Therapeutic Nihilism |
|
|
Cultural Views of Death |
| 3.7.1 | Funeral Rites |
| 3.7.2 | The "Good Death" |
| 3.7.3 | End of Life Care |
|
|
References |
|
|
Post Test |
|
|
Assessment Of The Geriatric… |
|
|
Module Objectives |
|
|
Domains of Assessment: Functional Assessment |
|
|
Domains Of Assessment: Psychosocial Health And Functioning |
| 4.3.1 | Informal Caregiving Support Network |
| 4.3.2 | Abuse and Neglect |
| 4.3.3 | Social Support |
| 4.3.4 | Spiritual and Cultural Assessment |
| 4.3.5 | Home Assessment |
|
|
Special Considerations In Assessment |
|
|
Post Test |
|
|
Health Care Policies |
|
|
Module Objectives |
|
|
The Policy-Making Process |
|
|
Financing Health & Long Term Care |
|
|
Quality Of Care Issues In Long Term Care |
|
|
Need And Access Across The Spectrum Of Care |
|
|
References |
|
|
Post Test |
|
|
Exploring Age-Related Body… |
|
|
Cardiovascular System |
| 6.1.1 | Case 1 |
| 6.1.2 | Case 2 |
| 6.1.3 | The Cardiovascular System |
| 6.1.4 | Can These Changes Be Modified? |
| 6.1.5 | Sodium and Activity |
| 6.1.6 | Atherosclerosis |
| 6.1.7 | What Can We Do About The Process? |
| 6.1.8 | Links to Theories of Aging |
| 6.1.9 | Myocardium |
| 6.1.10 | Clinical Implications |
| 6.1.11 | Cellular Calcium |
| 6.1.12 | Functional Changes |
| 6.1.13 | Pulse Wave Velocity |
| 6.1.14 | Additional Functional Changes |
| 6.1.15 | Clinical Significance |
| 6.1.16 | Response to Stress |
| 6.1.17 | Congestive Heart Failure |
| 6.1.18 | Diastolic Versus Systolic Heart Failure |
| 6.1.19 | Case 3 |
| 6.1.20 | Case 3: Points To Consider |
| 6.1.21 | References |
| 6.1.22 | Review Question 1 |
| 6.1.23 | Review Question 2 |
|
|
Endocrine System |
| 6.2.1 | Case 1: Mr. Jones |
| 6.2.2 | Circadian Rhythms |
| 6.2.3 | Hypothalamic-Pituitary and Hypothalamic-Pituitary-Adrenal Axis |
| 6.2.4 | Growth Hormone |
| 6.2.5 | Why Does Growth Hormone Decrease? |
| 6.2.6 | Why is Growth Hormone Important to Our Clinical Practice? |
| 6.2.7 | Is This Good Clinical Practice? |
| 6.2.8 | Case 2: Discussion |
| 6.2.9 | CRH, Adrenocorticotropic Hormone/Corticotropin (ACTH), and Cortisol |
| 6.2.10 | Aging, the Stress Response, Cortisol, and Cognitive Function |
| 6.2.11 | Aldosterone |
| 6.2.12 | Dehydroepiandrosterone (DHEA) |
| 6.2.13 | The Adrenal Medulla |
| 6.2.14 | Hypothalamic-Pituitary-Thyroid Axis |
| 6.2.15 | Posterior Pituitary |
| 6.2.16 | Case 3: Clinical |
| 6.2.17 | Endocrine Pancreas |
| 6.2.18 | What Causes These Changes? |
| 6.2.19 | Can These Changes Be Prevented? |
| 6.2.20 | What Do We See Clinically? |
| 6.2.21 | Discussion Point |
| 6.2.22 | Should Age-Related Changes in Carbohydrate Metabolism Be Treated? |
| 6.2.23 | Summary Case and Evaluation Questions |
| 6.2.24 | References |
| 6.2.25 | Review Question 1 |
| 6.2.26 | Review Question 2 |
|
|
Immune System |
| 6.3.1 | Setting the Stage |
| 6.3.2 | Setting the Stage 2 |
| 6.3.3 | Overview and Background |
| 6.3.4 | What Happens with Age? |
| 6.3.5 | Non-Specific Immunity |
| 6.3.6 | The Physical Barriers |
| 6.3.7 | Acid Contents of the Stomach |
| 6.3.8 | Phagocytosis |
| 6.3.9 | The Macrophage |
| 6.3.10 | The "Natural Killer" and the "LAK" |
| 6.3.11 | Non-Specific Summary |
| 6.3.12 | Specific Immunity |
| 6.3.13 | What Happens to Specific Immunity With Age? |
| 6.3.14 | The Immune Response |
| 6.3.15 | References |
|
|
Musculo-Skeletal System |
| 6.4.1 | Case 1 |
| 6.4.2 | Case 1 Continued |
| 6.4.3 | The Inter-Relationship of the Muscle and Skeletal System |
| 6.4.4 | Muscle Changes and Function with Age |
| 6.4.5 | Changes in Muscle with Age |
| 6.4.6 | Muscle Fibers |
| 6.4.7 | What Are The Physiologic Processes That Cause These Changes? |
| 6.4.8 | What Is The Impact Of These Changes On Function? |
| 6.4.9 | Mobility Changes |
| 6.4.10 | Interventions to Minimize Changes |
| 6.4.11 | Discussion Point |
| 6.4.12 | Joints, Tendons, and Ligaments |
| 6.4.13 | Differences in Cartilage Between Aging and Osteoarthritis |
| 6.4.14 | Skeletal Changes With Age |
| 6.4.15 | Bone Components |
| 6.4.16 | Many Factors Influence Bone Health |
| 6.4.17 | Bone Loss |
| 6.4.18 | General Changes in the Bone with Age |
| 6.4.19 | Factors Influencing Whether a Fracture Will Or Will Not Occur |
| 6.4.20 | Summary Case |
| 6.4.21 | References |
|
|
Neurological System |
|
|
Renal System |
|
|
Post Test |
Module 6: Exploring Age-Related Body Systems Changes6.1: Cardiovascular System6.1.6: AtherosclerosisUnlike arteriosclerosis, which may be less amenable to prevention, the process of atherosclerosis is modifiable. Plaque formation is a process that occurs over a long period of time, occurring in stages. One of the characteristics of atherosclerosis is the accumulation of cholesterol within the vessel wall (Badimon, et al, 1993). Cholesterol, like other forms of fat, is transported bound to proteins in complexes called lipoproteins. The major two lipoproteins that carry cholesterol are the low density lipoproteins (LDLs) and high density lipoproteins (HDLs). Fats deposited in atherosclerotic lesions are mainly from the LDLs while the HDLs appear to be involved with taking cholesterol back to liver to be metabolized—a process called “reverse cholesterol transport”. The process (which is vastly simplified here) starts with LDL and other lipids entering the vessel wall (See Figure 1 below). This is facilitated if the vessel wall has been damaged by chemical irritants such as tobacco smoke or by hypertension or by high levels of cholesterol in the blood.
The LDL can be oxidatively modified by what are termed “reactive oxygen species” or “free radicals” (Note: This link will open in a new browser window which you can close to return here). Once these LDL particles have been modified they are engulfed by macrophage cells, which are components of the immune system (Note: This link will open in a new browser window which you can close to return here). After engulfing a large amount of LDL, these macrophage cells become foam cells, which appear to be critical to the development and subsequent progression of the plaque. Although there are many other mechanisms that are involved in this process, these basic processes provide a basis for possible prevention. Mrs. Hazeltine, the 85 year old woman referred to in Case 1 (Note: This link will open in a new browser window which you can close to return here), was noted to have coronary artery disease, a problem generally involving the development of plaques. Given the process outlined above, what types of treatment modalities might be beneficial in preventing the progression of the atherosclerotic process? Stop and consider why and how they would work. What would your disciplines primary role be in implementing these treatment modalities? |

